Analysis of cytokine production by inflammatory mouse macrophages at the single‐cell level: selective impairment of IL‐12 induction in Leishmania ‐infected cells
暂无分享,去创建一个
[1] B. Kelsall,et al. Regulation of Interleukin-12 by Complement Receptor 3 Signaling , 1997, The Journal of experimental medicine.
[2] V. Maino,et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations , 1995, The Journal of experimental medicine.
[3] G. Trinchieri. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.
[4] R. Schaub,et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.
[5] R. Rerko,et al. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. , 1995, Journal of immunology.
[6] W. Beil,et al. Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice , 1992, Journal of leukocyte biology.
[7] D. Riches. Signalling heterogeneity as a contributing factor in macrophage functional diversity. , 1995, Seminars in cell biology.
[8] G. Trinchieri,et al. Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. , 1997, Journal of immunology.
[9] G. Trinchieri,et al. Mechanism of Suppression of Cell-Mediated Immunity by Measles Virus , 1996, Science.
[10] I. Katzenellenbogen. VACCINATION AGAINST ORIENTAL SORE: REPORT OF RESULTS OF FIVE HUNDRED AND FIFTY-FIVE INOCULATIONS , 1944 .
[11] P. Kaye,et al. Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro , 1992, Infection and immunity.
[12] G. Trinchieri,et al. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. , 1995, Journal of immunology.
[13] R. Rerko,et al. Recombinant interleukin 12 cures mice infected with Leishmania major , 1993, The Journal of experimental medicine.
[14] A. Sher,et al. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. , 1996, The Journal of infectious diseases.
[15] P. Kaye,et al. Dendritic cells, but not macrophages, produce IL‐12 immediately following Leishmania donovani infection , 1998, European journal of immunology.
[16] D. Berberian. CUTANEOUS LEISHMANIASIS (ORIENTAL SORE): I. TIME REQUIRED FOR DEVELOPMENT OF IMMUNITY AFTER VACCINATION , 1944 .
[17] S. Frankenburg,et al. In vitro secretion of cytokines by human mononuclear cells of individuals during and after cutaneous leishmaniasis infection , 1993, Parasite immunology.
[18] G. Trinchieri,et al. Infection with Leishmania major induces interleukin-12 production in vivo. , 1994, Immunology letters.
[19] A Radbruch,et al. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: Expression of interleukin‐10 in interferon‐γ and in interleukin‐4‐expressing cells , 1994, European journal of immunology.
[20] P. Kaye,et al. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice. , 1996, Experimental parasitology.
[21] R. Locksley,et al. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection , 1994, The Journal of experimental medicine.
[22] D. Snary,et al. Monoclonal antibodies to Leishmania tropica major: specificities and antigen location , 1982, Parasitology.
[23] H. Murray. Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. , 1997, The Journal of infectious diseases.
[24] W. de Souza,et al. Isolation and purification of amastigotes of Leishmania mexicana amazonensis by a gradient of Metrizamide. , 1983, The Journal of parasitology.
[25] Y. Belkaid,et al. Transient inducible events in different tissues: in situ studies in the context of the development and expression of the immune responses to intracellular pathogens. , 1994, Immunobiology.
[26] A. Sher,et al. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. , 1985, Journal of immunology.
[27] A. Descoteaux,et al. The lipophosphoglycan of Leishmania and macrophage protein kinase C. , 1993, Parasitology today.
[28] N. Reiner,et al. Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. , 1987, Journal of immunology.
[29] J. Louis,et al. Genetically resistant mice lacking interleukin‐12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response , 1996, European journal of immunology.
[30] P. Melby. Experimental leishmaniasis in humans: review. , 1991, Reviews of infectious diseases.
[31] F. Sutterwala,et al. Selective Suppression of Interleukin-12 Induction after Macrophage Receptor Ligation , 1997, The Journal of experimental medicine.
[32] R. Epand,et al. Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[33] E. Unanue,et al. Natural Immunity: A T‐Cell‐Independent Pathway of Macrophage Activation, Defined in the scid Mouse , 1991, Immunological reviews.
[34] D. Metcalfe,et al. Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+CD27- lymphocyte subpopulation. , 1995, Journal of immunology.
[35] R. Fauve,et al. Maintenance of granuloma macrophages in serum-free medium. , 1983, Journal of immunological methods.
[36] R. Badolato,et al. Promastigotes Selectively Inhibit Interleukin 12 Induction in Bone Marrow-derived Macrophages from Susceptible and Resistant Mice , 1996 .
[37] E. Carvalho,et al. Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis. , 1995, The American journal of tropical medicine and hygiene.
[38] G. Trinchieri,et al. Impaired interleukin 12 production in human immunodeficiency virus- infected patients , 1994, The Journal of experimental medicine.
[39] T. Hamilton,et al. The activated macrophage and granulomatous inflammation. , 1989, Current topics in pathology. Ergebnisse der Pathologie.